DIABETES Flashcards

You may prefer our related Brainscape-certified flashcards:
1
Q

criteria for diagnosis of metabolic syndrome

A
  • Waist circumference men >40in, women >35in (abd obesity)
  • Triglycerides >150
  • BP >130/85
  • FBS >100
  • HDL men less 40, women less than 50
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

criteria for diagnosis of pre-diabetes

A

FBS->100

A1C 5.7 – 6.4

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

criteria for diagnosis of T2DM

A

FBS->126

A1C >6.5

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Expected effect of insulin resistance on lipids and blood pressure.

A

(1) high levels of plasma triglycerides
(2) low levels of HDL
(3) the appearance of small dense low-density lipoproteins (sdLDL), as well as an excessive postprandial lipemia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What is the primary action of biguanides?

A

Decreases liver glucose production

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

What is the primary action of glitinides?

Ex: prandin, starlix

A

Increases insulin release in pancreas

“Mini - sulfonylureas”

hypoglycemia less of a problem

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

What is the primary action of sulfonylureas?

Ex: glyburide, glipizide, glimepiride

A

Increases insulin release in pancreas

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

What is the primary action of TZDs?

Ex: Actos, Avandia (glitazones)

A

Increases insulin sensitivity

Decrease glucose production by liver

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

What is the primary action of DPP-4-I?

Ex: Januvia, Tradjenta (gliptins)

A

Increases insulin secretion

Decreases glucagon secretion

Reduce both fasting and postprandial (after food) blood glucose levels, without causing weight gain.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

What is the primary action of SGLT2-I?

Ex: Invokana, Jardiance

A

Blocks glucose reabsorption by the kidney – increases glucosuria

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

What is the primary action of GLP-1?

Ex: Trulicity, Victoza (glutides)

A

Increases insulin secretion

Decreases glucagon secretion

Slows gastric emptying

Increases satiety

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

What is the primary action of insulin?

A

Increases glucose disposal

Decreases liver glucose production

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

What is the role of basal insulin?

A

The amount of insulin the patient needs to maintain a normal metabolic state when fasting.

Insulin needed even when patient is not eating (to control gluconeogenesis).

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

How do you know when the basal dose is correct?

A

if the blood sugar does not change when the patient is NPO [it is about ½ of the daily total; on average about 1 unit/hour in a person weighing 70 kg]

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

How is basal insulin dosed?

A

Weight based

0.1-1.5 u/kg/day—on average 0.6 units per kg/day is a good starting point

50% of this is basal

50% is meal time [15%/15%/20% split might work is patient eats smaller breakfast and lunch]

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

What are the ADA and AACE recommendations for starting a patient on basal insulin?

A

10 units of basal and increase 2 units every 3-4 days until fasting glucose is 100 mg/dL—that is the basal dose [may be at our calculated dose of 30 units or a bit more or less]

THEN you start the mealtime dosages—start with the largest meal

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

What is the starting basal insulin dose for an adult?

A

0.5-1 u/kg/d of body weight

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

What is the starting basal insulin dose for an older adult?

A

0.6 u/kg/d of body weight

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

What should the starting dose be if a patient is frail or small?

A

consider 0.2 u/kg/d to start—all as an evening dose

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

What is the role of correctional insulin?

A

insulin given to bring a high blood glucose level down to target range (with target usually below 150 mg/dL pre-meal, and below 200mg/dL at bedtime or 2am). Use rapid-acting insulin (aspart, lispro, or glulisine) or short-acting insulin (regular).

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

What is the role of nutritional insulin?

A

Insulin to cover carbohydrate intake from food, dextrose in IV fluid, tube feeds, TPN. Use rapid-acting insulin (aspart, lispro, or glulisine) or short-acting insulin (regular).

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

What is the role of bolus insulin?

A

Rapid acting insulin given either by syringe or pump

Correction bolus is given to lower a high BS—this is similar to old time “sliding scale” routines

Current moniker is mealtime bolus given to cover the amount of calories and CHO that patient is going to eat at the meal or at snack time [happy hour, birthday party, etc.].

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

How much on average does 1 unit of insulin lower BS by?

A

20 mg/dL

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

What should before meal glucoses [lunch and dinner] be?

A

140 mg or less

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
Q

What should 2 hour postprandial glucoses be around?

A

160 mg or less

26
Q

What is the ADA recommendation for starting mealtime/correction insulin?

A

starting 4 units with meals [start with largest meal], then increase by 2 units every 3-4 days until at target

27
Q

On average, 1 unit of insulin covers how many grams of CHO?

A

10 grams of CHO

28
Q

Which patients are not appropriate for intensified insulin therapy?

A

Those with glycemic control of 70-120 mg/dl and no complications

Those with hypoglycemic unawareness

Those who are poorly motivated and unwilling to check blood sugars several times a day

Those who have had DM <6-12 months

29
Q

What is the peak and duration for long acting (basal) insulin?

Ex: Detemir, glargine, degludec

A

Peak: Minimal hr

Duration: 20-36 hr

30
Q

What is the peak and duration for intermediate acting insulin?

Ex: NPH

A

Peak: 8-12 hr

Duration: 12-20 hr

31
Q

What is the peak and duration for short acting (regular) insulin?

A

Peak: 2-4 hr

Duration: 6-8 hr

32
Q

What is the peak and duration for rapid acting insulin?

Ex: aspart, glulisine, lispro

A

Peak: 1-2 hr

Duration: 3-5 hr

33
Q

Intensive Glycemic Control Does Not Reduce Macrovascular Risk in which patients?

A

Older Patients With Longer Duration of Disease

34
Q

What are the components of Macrovascular Risk Reduction?

A
  • Individualized glucose control
  • Hypertension control
  • Dyslipidemia control
  • Smoking cessation
  • Aspirin therapy
  • Diagnosis and management of:
    • – Autonomic cardiac neuropathy
    • – Kidney disease
35
Q

How do you manage diabetic nephropathy?

A

Optimal control of BP, lipids and BS

smoking cessation

ACE, ARB or renin inhibitor

Monitor K+

Nephrologist referral for Stg 4 CKD

36
Q

What is neuropathy?

A

loss of sensation, pain, burning

37
Q

What will improve the risk of neuropathy?

A

Decrease in A1C

38
Q

Diabetic Neuropathy Evaluation and tests

A

Foot inspection

  • ulcers
  • venous stasis disease

Neurologic testing

  • loss of sensation
  • ankle reflexes

Painful neuropathy

Cardiovascular autonomic neuropathy

  • HR variability with deep inspiration
  • valsalva manuever
  • change in position from prone to standing
39
Q

Dietary Recommendations for Diabetes

A

Low glycemic foods <55 out of 100 on index

healthy fats such as fish, nuts, avocado

CHO from fruits and vegetables (7-10 servings per day)

40
Q

What is the A1C reduction for AGIs?

A

0.7-1%

41
Q

What is the A1C reduction for Biguanides?

Ex: Metformin

A

1.5-2%

42
Q

What is the A1C reduction for GLP-1?

A

.78-1.9%

43
Q

What is the A1C reduction for SGLT2-I?

A

0.6-1%

44
Q

What is the A1C reduction for DPP-4-I?

A

0.56-0.59%

45
Q

What is the A1C reduction for TZDs?

A

0.5-1.5%

46
Q

What is the A1C reduction for sulfonylureas?

A

1-2%

47
Q

What factors should guide choice of oral anti-diabetic?

A

hypoglycemic risk

efficacy

impact on weight

potential side effects

cost

patient preference

48
Q

What is long term use of metformin associated with?

A

Vitamin B12 deficiency

49
Q

Current guidelines now state to consider initiating insulin therapy in

A

symptomatic newly diagnosed T2DM

A1C >10

FBS >300

50
Q

What organ does metformin (biguanide) target?

A

liver

51
Q

Metformin dosing and titrating

A

500mg BID with meals

Increase by 500 mg every 1-3 weeks

Max dose 2000mg

52
Q

Metformin side effects

A

GI upset

lactic acidosis

do not use in GFR <30 or in contrast media

age >80

53
Q

SGL2-I targets which organ?

A

Kidney

54
Q

SGLP2-I

A

yeast infections (due to glucosuria)

hyperkalemia

hypoglycemia

hypotension (due to volume depletion)

lower limb amputation risk, bone fx (Invokana)

recommended in this class if Jardiance due to decrease in CV risk

55
Q

What is the target organ(s) for TZDs?

Ex: Actos, Avandia

A

muscle, fat and liver

56
Q

How long until you see improvement with TZDs?

A

6-8 weeks

57
Q

Side effects of sulfonylureas

A

HYPOGLYCEMIA

weight gain

Contraindications: Advanced CKD, sulfa allergy

58
Q

Side effects of TZDs

A

swelling of legs

fluid retention

weight gain

Do not prescribe for CHF patients

59
Q

When should patients with type 2 diabetes have an
initial dilated and comprehensive eye examination
by an ophthalmologist or optometrist?

A

at the time
of the diabetes diagnosis and annually

60
Q

When targeting blood glucose targets, which glucose should you treat first?

A

FIX the FAST ( FBG) FIRST, then
go for postprandial